Clinical Trials
7 trialsNCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT05046444 2024-12-17
SIRIUS
Munich Leukemia Laboratory
Recruiting
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT02628379 2018-07-10
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Foundation Medicine
Completed
NCT01202786 2012-08-15
Cost-effectiveness Study of miRviewâ„¢ Mets in Patients With Cancer of Unknown Primary (CUP)
Teva Branded Pharmaceutical Products R&D, Inc.
Completed